Immunoglobulin heavy diversity 1-14 (IGHD1-14)

The immunoglobulin heavy diversity 1-14 (IGHD1-14) is a *diversity (D) gene segment* located within the human immunoglobulin heavy chain (IGH) locus on chromosome 14. It is one of many D gene segments that contribute to the variable (V), diversity (D), and joining (J) rearrangement process of the immunoglobulin heavy chain gene during B cell development. This process creates the vast repertoire of antibody specificities essential for adaptive immunity. IGHD1-14, like most D segments, is not individually expressed as a protein but acts as a DNA component that, after exon rearrangement, ultimately encodes part of the third complementarity-determining region (CDR3) of the immunoglobulin heavy chain variable region[6][7][1]. The GeneCards database explicitly notes that IGHD1-14 is "non-functional" in humans, meaning it is a pseudogene in many reference genomes and does not encode a functional product[7]. This further supports that it is not a druggable or therapeutic target, nor does it play a direct role in disease aside from broader immunogenetic contexts. Additionally, some of the alternative names (such as DM2, IGHD114) may reference the same or nearby segments based on differing immunogenetics databases, but do not correspond to a conventional drug target or protein[7]. **Key clarification:** - IGHD1-14 is NOT a canonical therapeutic target (such as a receptor, enzyme, transporter, transcription factor, etc.), but rather a DNA segment involved in adaptive immune gene rearrangement. - It is generally classified as "non-functional" (pseudogene) in human reference, so any use as a protein or drug target is incorrect[7]. - If used as a target name in pharmacology, immunotherapy, or clinical genetics, this is likely erroneous or based on a misunderstanding. **Summary statement:** The entry "immunoglobulin heavy diversity 1-14" (IGHD1-14) refers to a non-functional D gene segment within the immunoglobulin heavy chain locus and is not a protein, enzyme, receptor, or structure that would be considered a true therapeutic target[7][6][1].

Other names

IGHD114DM2IGHD1-14